Cytosorbents (CTSO) Asset Utilization Ratio (2012 - 2026)

Cytosorbents' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.88 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 21.94% year-over-year to 0.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.88 (up 21.94% YoY) and the FY2025 annual result came in at 0.81, up 14.1% from the prior year.
• Asset Utilization Ratio was 0.88 for Q1 2026 at Cytosorbents, up from 0.82 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.88 in Q1 2026 and bottomed at 0.48 in Q1 2022.
• A 5-year average of 0.68 and a median of 0.72 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 37.11% — and 2024, when it decreased 6.42%.
• Cytosorbents' Asset Utilization Ratio stood at 0.55 in 2022, then soared by 30.81% to 0.72 in 2023, then grew by 3.44% to 0.75 in 2024, then increased by 10.19% to 0.82 in 2025, then advanced by 6.51% to 0.88 in 2026.
• Business Quant data shows CTSO's Asset Utilization Ratio at 0.88 in Q1 2026, 0.82 in Q4 2025, and 0.79 in Q3 2025.